|Bid||80.20 x 1200|
|Ask||80.50 x 1300|
|Day's Range||78.76 - 81.82|
|52 Week Range||62.55 - 217.25|
|Beta (5Y Monthly)||1.62|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 21, 2024 - Feb 26, 2024|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||134.16|
Subscribe to Yahoo Finance Plus to view Fair Value for MRNA
Iovance Biotherapeutics (IOVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Key Insights Given the large stake in the stock by institutions, Moderna's stock price might be vulnerable to their...
The Company's ESG strategy demonstrates its efforts to advance global health and environmental sustainability, as well as its commitments to employees and communitiesCAMBRIDGE, MA / ACCESSWIRE / December 7, 2023 / Moderna, Inc. (NASDAQ:MRNA) today ...